Skip to main content

Table 4 MetS according to different diagnosis and hazard ratios for incident clinical endpoints corrected for individual components

From: The clinical value of metabolic syndrome and risks of cardiometabolic events and mortality in the elderly: the Rotterdam study

 

AHA/NHLBI

IDF

EGIR

Type 2 diabetes mellitus

MetS 1.19 (0.90–1.58)

MetS 1.11 (0.82–1.49)

MetS 0.91 (0.56–1.49)

GLYC 4.01 (3.30–4.87)*

GLYC 4.20 (3.45–5.12)*

GLYC 5.12 (4.38–5.98)*

HDL 1.48 (1.24–1.76)*

HDL 1.52 (1.29–1.80)*

DYSL 1.64 (1.40–1.92)*

WC 1.48 (1.23–1.78)*

BP 1.34 (1.08–1.65)*

WC 1.33 (1.08–1.64)*

BP 1.28 (1.04–1.58)*

COB 1.33 (0.99–1.78)

INSUL 1.54 (0.98–2.44)

TRIG 1.24 (1.04–1.49)*

TRIG 1.32 (1.12–1.55)*

BP 1.39 (1.18–1.64)*

Coronary heart disease

MetS 0.73 (0.53–1.01)

MetS 1.18 (0.86–1.58)

MetS 1.00 (0.55–1.81)

BP 1.67 (1.31–2.14)*

BP 1.53 (1.20–1.95)*

BP 1.50 (1.23–1.82)*

TRIG 1.48 (1.18–1.85)*

TRIG 1.29 (1.04–1.59)*

DYSL 1.36 (1.12–1.67)*

WC 1.38 (1.11–1.71)*

HDL 1.17 (0.95–1.44)

WC 1.10 (0.90–1.35)

HDL 1.34 (1.07–1.68)*

COB 0.99 (0.76–1.28)

GLYC 0.93 (0.74–1.18)

GLYC 0.94 (0.77–1.15)

GLYC 0.82 (0.67–1.01)

INSUL 0.87 (0.50–1.52)

Stroke

MetS 1.09 (0.76–1.58)

MetS 1.12 (0.80–1.56)

MetS 0.91 (0.46–1.77)

BP 1.44 (1.10–1.89)*

BP 1.42 (1.08–1.86)*

BP 1.44 (1.16–1.79)*

HDL 1.36 (1.06–1.75)*

HDL 1.35 (1.07–1.71)*

GLYC 1.22 (0.96–1.56)

WC 1.06 (0.83–1.34)

COB 1.11 (0.83–1.48)

WC 1.20 (0.95–1.52)

GLYC 0.98 (0.78–1.22)

GLYC 0.96 (0.76–1.21)

DYSL 1.11 (0.88–1.41)

TRIG 0.84 (0.65–1.10)

TRIG 0.84 (0.66–1.08)

INSUL 0.87 (0.47–1.61)

Cardiovascular mortality

MetS 0.86 (0.58–1.27)

MetS 1.06 (0.74–1.54)

MetS 0.79 (0.40–1.57)

BP 1.47 (1.10–1.97)*

BP 1.39 (1.04–1.86)*

BP 1.35 (1.07–1.69)*

TRIG 1.24 (0.94–1.62)

COB 1.21 (0.89–1.63)

WC 1.30 (1.01–1.67)*

WC 1.21 (0.94–1.55)

TRIG 1.14 (0.89–1.47)

GLYC 1.14 (0.88–1.47)

HDL 1.13 (0.86–1.48)

HDL 1.05 (0.81–1.35)

DYSL 1.07 (0.84–1.37)

GLYC 1.00 (0.79–1.26)

GLYC 0.92 (0.71–1.18)

INS 1.00 (0.54–1.86)

All-cause mortality

MetS 0.97 (0.82–1.14)

MetS 0.98 (0.85–1.14)

MetS 0.81 (0.62–1.05)

HDL 1.25 (1.11–1.41)*

HDL 1.24 (1.11–1.39)*

INSUL 1.18 (0.93–1.50)

BP 1.09 (0.97–1.22)

BP 1.08 (0.97–1.22)

DYSL 1.15 (1.03–1.27)*

WC 1.02 (0.92–1.13)

COB 1.05 (0.93–1.18)

GLYC 1.11 (0.99–1.24)

GLYC 1.00 (0.90–1.10)

GLYC 0.99 (0.89–1.10)

BP 1.10 (1.00–1.21)*

TRIG 0.97 (0.86–1.10)

TRIG 0.96 (0.86–1.08)

WC 1.04 (0.94–1.15)

  1. Data are presented as hazard ratios with 95 % confidence intervals. All analysis corrected for age and sex
  2. AHA/NHLBI, American heart association/national heart, lung, and blood institute; IDF, International Diabetes Federation; EGIR, European group for the study of Insulin Resistance; GLYC, hyperglycemia; BP, hypertension; TRIG, hypertriglyceridemia; HDL, low HDL-cholesterol; WC, increased waist circumference; COB, central obesity; DYSL, dyslipidemia; INS, highest quartile of fasting Insulin not having type 2 diabetes
  3. * Statistically significant